Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy

Circulation

Volumn 120, Issue 13, 2009, Pages 1248-1254

  Jensen, Kurt W ^a   Kerr, Kim M ^a   Fedullo, Peter F ^a   Kim, Nick Hyong ^a   Test, Victor J ^a   Ben Yehuda, Ori ^a   Auger, William R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Embolism; Hypertension; Pulmonary; Pulmonary heart disease; Surgery; Thrombus

Indexed keywords

AMBRISENTAN; ANTICOAGULANT AGENT; BOSENTAN; DIGOXIN; DIURETIC AGENT; DOPAMINE; ILOPROST; PROSTACYCLIN; SILDENAFIL; SPIRONOLACTONE; TADALAFIL; UNIPROST;

ARTICLE; BLEEDING; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; DEMOGRAPHY; DRUG COMBINATION; ENDARTERECTOMY; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG ARTERY PRESSURE; LUNG INJURY; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; RETROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; DIURETICS; ENDARTERECTOMY; HOSPITAL MORTALITY; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; PREVALENCE; PULMONARY EMBOLISM; PULMONARY WEDGE PRESSURE; REFERRAL AND CONSULTATION; REPERFUSION INJURY; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 70349667179     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.865881     Document Type: Article

References (11)

1. Peacock A, Simonneau G, Lewis R. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:608-614. (Pubitemid 44411628)
2. Pengo V, Lensing A, Prins M, Marchiori A, Davidson B, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Thrombo-embolic pulmonary hypertension study group: incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-2264.
3. Galiè N, Kim N. Pulmonary microvascular disease in chronic thrombo-embolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:571-576. (Pubitemid 44411622)
4. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thrombo-embolic pulmonary hypertension. Clin Chest Med. 2007;28:255-269.
5. Hartz RS, Byrne JG, Levitsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg. 1996;62: 1255-1260.
6. Jamieson S, Kapelanski D, Sakakibara N, Manecke G, Thistlethwaite P, Kerr K, Channick R, Fedullo P, Auger W. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003; 76:1457-1464.
7. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23: 595-600.
8. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123:338-343. (Pubitemid 36269413)
9. Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg. 2003;76:711-718. (Pubitemid 37100727)
10. Reesink H, Surie S, Kloek JJ, Tan HL, Fedullo PF, Bresser P. Bosentan as bridge to pulmonary endarterectomy in patients with chronic throm-boembolic pulmonary hypertension. In: Reesink H, ed. Identification of Preoperative Risk-Factors and Parameters of Outcome in Chronic Thromboembolic Pulmonary Hypertension. Amsterdam, Netherlands: Gravo Groep Purmerend; 2007:113-127
11. McLaughlin V, Archer S, Badesch D, Barst B, Farber H, Lindner J, Mathier M, McGoon M, Park M, Rosenson R, Rubin L, Tapson V, Varga J. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573-1619.